Degarelix is a peptide and selective GnRH (human gonadotropin-releasing hormone) receptor antagonist that treats prostate cancer by lowering testosterone levels in the body.
Molecular Weight:
1632.26
Purity:
99.34%
CAS Number:
[214766-78-6]
Formula:
C82H103ClN18O16
Target:
GNRH Receptor|||Apoptosis
T10988
T10988
* VAT and and shipping costs not included. Errors and price changes excepted